Beta-Blocker

BOSTON — Optimizing HF therapy is the best way to reduce disease morbidity and mortality and clinicians should consider personalizing and titrating guideline-directed medical therapy based on patient comorbidities, according to a speaker.

In a large cohort of patients with spontaneous coronary artery dissection, the rates of mortality and recurrent spontaneous coronary artery dissection were low at 3 years, researchers reported.

Data from a meta-analysis show that a 20% improvement in CV medication adherence could reduce risk for any CV event by 8% and risk for all-cause mortality by 12% among patients with CAD, researchers reported.

Angiotensin receptor blockers and beta-blockers slow down the expansion of the aorta in patients with Marfan syndrome and no previous aortic surgery, according to data reported at the European Society of Cardiology Congress.

Initiation of oral beta-blockers within 24 hours following PCI for ACS was associated with reduced risk for in-hospital bleeding and mortality compared with nonuse, researchers reported.

WASHINGTON — In this Healio video exclusive, the vice chair of a new guideline on the management of HF discusses the biggest takeaways.

WASHINGTON — A joint guideline from the American College of Cardiology, the American Heart Association and the Heart Failure Society of America redefines HF stages to focus on prevention and recommends HF treatment with SGLT2 inhibitors.

In patients with HF with reduced ejection fraction, those with frailty had elevated risk for poor outcomes but less likelihood of being on optimal guideline-directed medical therapy, according to new data from the GUIDE-IT trial.

Use of beta blockers did not affect outcomes among patients treated with immunotherapy for unresectable hepatocellular carcinoma, according to study results presented at ASCO Gastrointestinal Cancers Symposium.

Patients with a history of myocardial infarction are unlikely to receive prescriptions for angiotensin-converting enzyme/angiotensin receptor blockers, beta-blockers or statins if they are also survivors of AKI, according to findings.